IU researchers are taking part in a COVID-19 immunity study.

IU to research COVID-19 reinfection, immunity

NEW YORK — Pfizer and German company BioNTech announced on Monday, November 9, that their coronavirus vaccine is more than 90 percent effective in preventing COVID-19 in those who have not previously been infected with the virus. Reuters reports that…